6360031|t|Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease.
6360031|a|Ten patients with mild to severe Alzheimer's disease were treated for up to 10 months with 10 to 15 mg oral physostigmine daily or with placebo, according to a single blind, multiple crossover protocol. No clinically meaningful improvement occurred with physostigmine treatment.
6360031	42	55	physostigmine	Chemical	MESH:D010830
6360031	59	78	Alzheimer's disease	Disease	MESH:D000544
6360031	84	92	patients	Species	9606
6360031	113	132	Alzheimer's disease	Disease	MESH:D000544
6360031	188	201	physostigmine	Chemical	MESH:D010830
6360031	334	347	physostigmine	Chemical	MESH:D010830
6360031	Negative_Correlation	MESH:D010830	MESH:D000544

